View PDF Version
 
DOI: 10.1039/A707728I (Paper) Reference Section for: Analyst, 1998, 123, 889-892

Speciation and absolute bioavailability: risk assessment of arsenic-contaminated sites in a residential suburb in Canberra†

(Note: The full text of this document is currently only available in the PDF Version )

Jack C. Ng, Sharon M. Kratzmann, Lixia Qi, Michael R. Moore, Hugh Crawley and Barry Chiswell

Abstract

Watson is a fully developed suburb of some 30 years in Canberra (the capital city of Australia). A plunge dip using arsenical pesticides for tick control was operated there between 1946 and 1960. Chemical investigations revealed that many soil samples obtained from the study area contained levels of arsenic exceeding the current health-based investigation levels of 100 mg kg–1 set by the National Health and Medical Research Council in Australia. For the speciation study, nine composite samples of surface and sub-surface soils and a composite sample of rocks were selected. ICP-MS analysis showed that arsenic levels in these samples ranged from 32 to 1597 mg kg–1. Chemical speciation of arsenic showed that the arsenite (trivalent) components were 0.32–56% in the soil and 44.8% in the rock composite samples. Using a rat model, the absolute bioavailability of these contaminated soils relative to As3+ or As5+ ranged from 1.02 to 9.87% and 0.26 to 2.98%, respectively. An attempt was made to develop a suitable leachate test as an index of bioavailability. However, the results indicated that there was no significant correlation between the bioavailability and leachates using neutral pH water or 1 M HCl. Our results indicate that speciation is highly significant for the interpretation of bioavailability and risk assessment data; the bioavailable fractions of arsenic in soils from Watson are small and therefore the health impact upon the environment and humans due to this element is limited.

References

  1. A. Tessier, P. G. C. Campbell and M. Bisson, Anal. Chem., 1979, 51, 844 CrossRef CAS.
  2. W. F. Pickering, CRC Crit. Rev. Anal. Chem., 1981, 12, 233 Search PubMed.
  3. U. Förstner, Anal. Chem., 1983, 316, 604 CrossRef.
  4. G. A. Pascoe, R. J. Blanchet and G. Linder, Arch. Environ. Contam. Toxicol., 1994, 27(1), 44 CAS.
  5. K. Groen, H. A. M. G. Vaessen, J. J. G. Kliest, J. L. M. Deboer, T. Vanooik, A. Timmerman and R. F. Vlug, Environ. Health Perspect., 1994, 102(2), 182 CAS.
  6. G. B. Freeman, J. D. Johnson, S. C. Liao, R. A. Schoof and P. D. Bergstrom, in Proceedings of International Conference on Arsenic Exposure and Health Effects, New Orleans, July 28–30, 1993, SEGH, Los Angeles, 1993, pp. 8–10 Search PubMed.
  7. J. Chappell, B. Chiswell and H. Olszowy, Talanta, 1995, 42(3), 323 CrossRef CAS.
  8. D. C. Fenwick and J. K. Blackshaw, Lab. Anim., 1989, 23, 220 Search PubMed.
  9. E. A. Woolson, in Biological and Environmental Effects of Arsenic, ed. Fowler, B. A., Elsevier, Amsterdam, 1983, pp. 51–139 Search PubMed.
  10. K. W. McDougall, in Proceedings of Risk Assessment Workshop, ed. Powell, I., State Pollution Control Commission, Sydney, NSW, 1991, pp. 1–24 Search PubMed.
  11. J. C. Ng, K. W. McDougall, P. Imray, A. Hertle and A. A. Seawright, in Proceedings (on Disks) of the 12th Australian Symposium on Analytical Chemistry/3rd Environmental Chemistry Conference, Perth, 26 September–1 October 1993, Royal Australian Chemical Institute, Melbourne, 1993, 6pp Search PubMed.
  12. K. S. Squibb and B. A. Fowler, in Biological and Environmental Effects of Arsenic, ed. Fowler, B. A., Elsevier, Amsterdam, 1983, pp. 233–269 Search PubMed.
  13. ATSDR (Agency for Toxic Substances and Disease Registry), Toxicological Profile of Arsenic, US Public Health Service, Atlanta, GA, 1993 Search PubMed.
  14. G. B. Freeman, J. D. Johnson, J. M. Killinger, S. C. Liao, A. O. Davis, M. V. Ruby, R. L. Chaney, S. C. Lovre and P. D. Bergstrom, Fundam. Appl. Toxicol., 1993, 21, 83 CrossRef CAS.
  15. B. A. Owen, Regul. Toxicol. Pharmacol., 1990, 11, 237 CrossRef CAS.
  16. Y. Odanaka, O. Matan and S. Goto, Bull. Environ. Contam. Toxicol., 1980, 24, 452 CAS.
  17. S. Chong, K. Dill and E. McGown, J. Biochem. Toxicol., 1989, 4(1), 39 CAS.
  18. J. C. Ng and M. R. Moore, in The Health Risk Assessment and Management of Contaminated Sites, ed. Langley, A., Markey, B., and Hill, H., Public and Environmental Health Service, South Australian Health Commission, South AustraliaContaminated Sites Monograph Series, No. 5, 1996, pp. 355–363 Search PubMed.
  19. M. Vahter, in Arsenic Exposure and Health, ed. Chappell, W. R., Abernathy, C. O., and Cothern, C. R., Science and Technology Letler, Northwood, UK, 1994, pp. 171–179 Search PubMed.
  20. A. Davis, M. V. Ruby and P. D. Bergstrom, Environ. Sci. Technol., 1992, 26(3), 461 CAS.